Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation-Reference-Cited by-同舟云学术

Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation

Published:2024 Issue: Volume: Page:
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

El-Nagar Mohamed K. S.¹^ORCID,Shahin Mai I.²,El-Behairy Mohammed F.¹,Taher Ehab S.³⁴,El-Badawy Mohamed F.⁵,Sharaky Marwa⁶,Abou El Ella Dalal A.²,Abouzid Khaled A. M.²^ORCID,Adel Mai²

Affiliation:

1. Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia, 32897, Egypt

2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, 11566, Egypt

3. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, 71524, Egypt

4. Department of Basic Medical and Dental Sciences, Faculty of Dentistry, Zarqa University, Zarqa, 13110, Jordan

5. Department of Microbiology and Immunology, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia, 32897, Egypt

6. Department of Cancer Biology, Pharmacology Unit, National Cancer Institute (NCI), Cairo University, Cairo, Egypt

Abstract

Discovery of novel pyridazinone derivatives with dual antimicrobial and anticancer activities.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MD/D4MD00481G

Reference61 articles.

1. Quinoline–imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity

2. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

3. Methicillin-Resistant and -SusceptibleStaphylococcus aureusSequence Type 398 in Pigs and Humans

4. Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity.

5. Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients